Page 17 - Molecular Testing News Today : Breaking News, Live Updates & Top Stories | Vimarsana

To address challenges with error-prone, manual molecular testing workflows, Thermo Fisher Scientific has introduced Diomni Enterprise Software, to help streamline routine diagnostics testing for standardization and faster time-to-results. By connecting the individual steps of the workflow in one unified platform, Diomni Enterprise can increase a lab’s ability to dynamically respond to today’s rapidly changing testing environment. The solution can be used by a variety of labs performing r

A panel of experts offers their insights into which patients with resectable early-stage NSCLC might be suitable for neoadjuvant versus adjuvant chemoimmunotherapy.

Shared perspective on the armamentarium of molecular testing assays in non–small cell lung cancer and how results can be best interpreted when selecting treatment.

By Chris Wack CareDx shares were up 10% at $10.69 after the company said its AlloSure Lung donor-derived cell-free DNA molecular testing service has received...

AlloSure Lung Represents First dd-cfDNA Approved by Medicare for Lung Transplant Patients